The recoveryELISA RTA is for research use only and not to be used in diagnostic procedures.

• Dynamic Range: Adalimumab: 0.7 – 30 µg/mL; TNF alpha in sample without Adalimumab: 4-400ng/ml;TNF alpha in sample with Adalimumab: 4-160ng/ml
• Sensitivity: Adalimumab: 0.7 µg/mL; TNF alpha: 4ng/ml
• Incubation: overnight

Tumour necrosis factor (TNFα) is a signalling substance of the immune system which can cause, among other things, the formation of inflammatory mediators in cells. In inflammatory diseases such as rheumatoid arthritis, there is overproduction of TNFα, which can be inhibited by using therapeutic antibodies.